← Back to Clinical Trials
Recruiting NCT07751237

NCT07751237 Diaphragmatic Ultrasonography in Difficult Weaning

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07751237
Status Recruiting
Phase
Sponsor Hospital de Clinicas de Porto Alegre
Condition Weaning Mechanical Ventilation
Study Type INTERVENTIONAL
Enrollment 220 participants
Start Date 2026-08
Primary Completion 2028-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Diaphragmatic ultrasound

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 220 participants in total. It began in 2026-08 with a primary completion date of 2028-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Weaning from mechanical ventilation (MV) is a gradual process that includes several steps until the complete withdrawal of ventilatory support. Difficult weaning is defined as weaning completed only after the first attempt to withdraw the patient from ventilatory support, that is, a patient who failed the first spontaneous breathing trial (SBT). The use of ultrasound (US) to assess diaphragmatic and extradiaphragmatic muscles, such as the parasternal muscles, has been employed to determine diaphragmatic dysfunction and ventilatory effort, contributing to the decision-making process regarding weaning. Among the tools used for bedside monitoring and evaluation of patients are ventilatory variables that indicate an adequate level of ventilatory assistance in spontaneous modes through ventilatory drive, such as P0.1 (occlusion pressure in the first 100 ms) and assessment of ventilatory effort-inspiratory muscle pressure (Pmus)-which have also contributed to the downscaling of ventilatory support. However, there is still no consensus in the literature regarding predicted values or the effective role of these tools as predictors of weaning during the spontaneous breathing trial (SBT). The available studies investigating the relationship between diaphragmatic US, through measurements of diaphragmatic excursion and thickening fraction, and weaning failure from mechanical ventilation are mostly observational, which limits the strength of the current evidence. Therefore, it is essential to conduct randomized clinical trials, which are still unprecedented on this topic, to more robustly assess the efficacy of this technique as a decision-support tool during the weaning process, thereby contributing to more precise clinical practice. OBJECTIVES: The primary objective of this study is to evaluate the effect of diaphragmatic US use on ventilator-free days in patients with difficult weaning. The secondary objective is to analyze the relationship between the ventilatory variables P0.1 and Pmus, diaphragmatic US, and parasternal muscle recruitment during the SBT. METHODS: This is a randomized clinical trial, following CONSORT recommendations, which will be prospectively registered on the ClinicalTrials platform. Patients will be included after failing the first SBT. Subsequently, they will be randomized into two groups: In the shared US group, the results of diaphragmatic assessment via US will be shared with the attending team for decision-making regarding extubation. In the second group, the non-shared US group, the attending team will not have access to the diaphragmatic assessment for decision-making. EXPECTED RESULTS: It is expected that the shared US group of patients will have a shorter duration of MV and a lower number of extubation failures.

Eligibility Criteria

Inclusion Criteria: * Adults patients receiving invasive mechanical ventilation who are classified as having difficult weaning, defined as failure of the first spontaneous breathing trial. * Richmond Agitation-Sedation Scale (RASS) score between -2 and +1. * Clinical stability, defined as: * No vasopressor support or only low-dose, stable vasopressor therapy. * Absence of significant cardiac arrhythmias or ongoing myocardial ischemia. * Adequate oxygenation (SpO₂ \>90% or PaO₂ \>60 mmHg). * Respiratory rate \<35 breaths/min. Exclusion Criteria: * Inability to obtain informed consent. * Pre-existing neuromuscular disease. * Pregnancy. * Inability to perform the ultrasound examination because of chest drains, surgical wounds, or skin lesions at the assessment sites.

Contact & Investigator

Central Contact

Cassiano Teixeira, Doctor

✉ cassiano.rush@gmail.com

📞 +55 51 999687962

Principal Investigator

Cassiano Teixeira, Doctor

PRINCIPAL INVESTIGATOR

Hospital de Clínicas de Porto Alegre - RS, Brasil

Frequently Asked Questions

Who can join the NCT07751237 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Weaning Mechanical Ventilation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07751237 currently recruiting?

Yes, NCT07751237 is actively recruiting participants. Contact the research team at cassiano.rush@gmail.com for enrollment information.

Where is the NCT07751237 trial being conducted?

This trial is being conducted at Porto Alegre, Brazil.

Who is sponsoring the NCT07751237 clinical trial?

NCT07751237 is sponsored by Hospital de Clinicas de Porto Alegre. The principal investigator is Cassiano Teixeira, Doctor at Hospital de Clínicas de Porto Alegre - RS, Brasil. The trial plans to enroll 220 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology